Relx Plc (NYSE:RELX) Shares Sold by Snowden Capital Advisors LLC

Snowden Capital Advisors LLC decreased its holdings in shares of Relx Plc (NYSE:RELX) by 13.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,717 shares of the technology company’s stock after selling 2,500 shares during the quarter. Snowden Capital Advisors LLC’s holdings in Relx were worth $714,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. LGT Group Foundation acquired a new stake in shares of Relx during the 4th quarter worth approximately $257,000. Paradigm Asset Management Co. LLC grew its stake in Relx by 17.1% during the 4th quarter. Paradigm Asset Management Co. LLC now owns 81,600 shares of the technology company’s stock worth $3,706,000 after buying an additional 11,900 shares during the last quarter. Smartleaf Asset Management LLC increased its position in Relx by 120.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 12,066 shares of the technology company’s stock worth $548,000 after buying an additional 6,588 shares during the period. Merit Financial Group LLC bought a new stake in Relx in the fourth quarter valued at $301,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Relx by 19.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 143,483 shares of the technology company’s stock valued at $6,517,000 after acquiring an additional 23,183 shares during the period. Institutional investors and hedge funds own 15.02% of the company’s stock.

Relx Stock Up 0.8%

Relx stock opened at $54.99 on Tuesday. Relx Plc has a 52 week low of $43.28 and a 52 week high of $55.21. The stock has a market cap of $101.51 billion, a price-to-earnings ratio of 29.56, a PEG ratio of 2.73 and a beta of 0.86. The company’s 50-day moving average price is $51.28 and its two-hundred day moving average price is $48.98. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46.

Wall Street Analysts Forecast Growth

RELX has been the topic of a number of analyst reports. The Goldman Sachs Group initiated coverage on shares of Relx in a report on Wednesday, March 26th. They issued a “buy” rating on the stock. Morgan Stanley restated an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th. StockNews.com downgraded Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Finally, Barclays raised Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy”.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.